• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Precision Pathology as Part of Precision Medicine: Are We Optimizing Patients' Interests in Prioritizing Use of Limited Tissue Samples?

作者信息

McCall Shannon J, Dry Sarah M

机构信息

Duke University, Durham, NC.

University of California at Los Angeles, Los Angeles, CA.

出版信息

JCO Precis Oncol. 2019 Dec;3:1-6. doi: 10.1200/PO.18.00238.

DOI:10.1200/PO.18.00238
PMID:35100673
Abstract
摘要

相似文献

1
Precision Pathology as Part of Precision Medicine: Are We Optimizing Patients' Interests in Prioritizing Use of Limited Tissue Samples?精准病理学作为精准医学的一部分：我们是否在优先使用有限组织样本时优化了患者的利益？
JCO Precis Oncol. 2019 Dec;3:1-6. doi: 10.1200/PO.18.00238.
2
Optimizing Precision Medicine for Public Health.优化公共卫生领域的精准医学
Front Public Health. 2019 Mar 7;7:42. doi: 10.3389/fpubh.2019.00042. eCollection 2019.
3
Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.前分析和精准病理学：为精准医学确保癌症患者生物标本分子完整性的病理学实践。
Arch Pathol Lab Med. 2019 Nov;143(11):1346-1363. doi: 10.5858/arpa.2019-0009-SA. Epub 2019 Jul 22.
4
Respiratory healthcare by design: Computational approaches bringing respiratory precision and personalised medicine closer to bedside.设计驱动的呼吸健康护理：计算方法让呼吸精准医疗和个性化医疗更贴近床边。
Morphologie. 2019 Dec;103(343):194-202. doi: 10.1016/j.morpho.2019.10.042. Epub 2019 Nov 8.
5
[Development of ophthalmic pathology and precision medicine].[眼科病理学与精准医学的发展]
Zhonghua Yan Ke Za Zhi. 2016 Oct 11;52(10):724-727. doi: 10.3760/cma.j.issn.0412-4081.2016.10.002.
6
Factors that drive the increasing use of FFPE tissue in basic and translational cancer research.推动FFPE组织在基础和转化癌症研究中使用日益增加的因素。
Biotech Histochem. 2018;93(5):373-386. doi: 10.1080/10520295.2018.1446101. Epub 2018 Aug 16.
7
Responsible use of organoids in precision medicine: the need for active participant involvement.精准医学中器官类器官的合理应用：需要积极的参与者投入。
Development. 2020 Apr 6;147(7):dev177972. doi: 10.1242/dev.177972.
8
Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance.卵巢癌精准医学检测：商业保险患者与医疗补助保险患者之间日益扩大的不公平差距。
Gynecol Oncol. 2021 Jul;162(1):18-23. doi: 10.1016/j.ygyno.2021.04.025. Epub 2021 May 4.
9
The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.病理学在个性化（精准）医学时代的作用：简要综述。
Acta Med Acad. 2021 Apr;50(1):47-57. doi: 10.5644/ama2006-124.325.
10
Precision medicine, agriculture, and genome editing: science and ethics.精准医学、农业和基因组编辑：科学与伦理。
Ann N Y Acad Sci. 2020 Apr;1465(1):59-75. doi: 10.1111/nyas.14266. Epub 2019 Nov 13.

引用本文的文献

1
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.对ORACLE（一种与肺腺癌患者生存相关的克隆表达生物标志物）进行前瞻性验证。
Nat Cancer. 2025 Jan;6(1):86-101. doi: 10.1038/s43018-024-00883-1. Epub 2025 Jan 9.
2
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer.大规模数字基因表达分析揭示了晚期肺癌腺癌和鳞状细胞癌中免疫检查点抑制剂治疗的不同预测特征。
BMC Cancer. 2022 Feb 8;22(1):154. doi: 10.1186/s12885-022-09264-2.
3
Selection of Representative Histologic Slides in Interobserver Reproducibility Studies: Insights from Expert Review for Ovarian Carcinoma Subtype Classification.
观察者间可重复性研究中代表性组织学切片的选择：卵巢癌亚型分类专家评审的见解
J Pathol Inform. 2021 Mar 22;12:15. doi: 10.4103/jpi.jpi_56_20. eCollection 2021.
4
Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing.处于优化肿瘤组织诊断流程以提高诊断准确性和分子检测水平前沿的病理学家。
Am J Clin Pathol. 2021 May 18;155(6):781-792. doi: 10.1093/ajcp/aqaa212.
5
Pathology Laboratory Policies and Procedures for Releasing Diagnostic Tissue for Cancer Research.病理学实验室发布癌症研究用诊断组织的政策和程序。
Arch Pathol Lab Med. 2021 Feb 1;145(2):222-226. doi: 10.5858/arpa.2019-0474-OA.
6
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.荷兰非小细胞肺癌新型分子生物标志物的应用：如何应对日益增加的复杂性
Front Oncol. 2020 Jan 22;9:1521. doi: 10.3389/fonc.2019.01521. eCollection 2019.